XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers

Zhifeng Zhang; Fufu Zheng; Zhenlong Yu; Jiajiao Hao; Miao Chen; Wendan Yu; Wei Guo; Yiming Chen; Wenlin Huang; Zhijun Duan; Wuguo Deng

doi:10.1371/journal.pone.0186900

Loading metrics

Open Access

Peer-reviewed

Research Article

XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers

Zhifeng Zhang ,

Contributed equally to this work with: Zhifeng Zhang, Fufu Zheng, Zhenlong Yu

Roles Formal analysis, Investigation, Visualization, Writing – original draft

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
⨯
Fufu Zheng ,

Contributed equally to this work with: Zhifeng Zhang, Fufu Zheng, Zhenlong Yu

Roles Methodology

Affiliation The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
⨯
Zhenlong Yu ,

Contributed equally to this work with: Zhifeng Zhang, Fufu Zheng, Zhenlong Yu

Roles Data curation, Formal analysis, Investigation, Methodology, Visualization

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
⨯
Jiajiao Hao,

Roles Investigation

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
⨯
Miao Chen,

Roles Resources

Affiliation SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China
⨯
Wendan Yu,

Roles Resources

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
⨯
Wei Guo,

Roles Resources

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
⨯
Yiming Chen,

Roles Methodology

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
⨯
Wenlin Huang,

Roles Resources

Affiliations SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China, State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China
⨯
Zhijun Duan ,

Roles Conceptualization, Project administration, Supervision, Writing – review & editing

* E-mail: cathydoctor@sina.com (ZD); dengwg@sysucc.org.cn (WD)

Affiliation The First Affiliated Hospital & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China

http://orcid.org/0000-0001-7976-4959

⨯
Wuguo Deng

Roles Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Writing – review & editing

* E-mail: cathydoctor@sina.com (ZD); dengwg@sysucc.org.cn (WD)

Affiliations SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China, State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China
⨯

XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers

Zhifeng Zhang,
Fufu Zheng,
Zhenlong Yu,
Jiajiao Hao,
Miao Chen,
Wendan Yu,
Wei Guo,
Yiming Chen,
Wenlin Huang,
Zhijun Duan

Published: October 19, 2017
https://doi.org/10.1371/journal.pone.0186900

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
COX-2 inhibitors
Is the Subject Area "COX-2 inhibitors" applicable to this article?

Thanks for your feedback.
Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.